Literature DB >> 9442808

Elevated lipoprotein lipids and gestational hormones in women with diet-treated gestational diabetes mellitus compared to healthy pregnant controls.

S C Couch1, E H Philipson, R B Bendel, L M Pujda, R A Milvae, C J Lammi-Keefe.   

Abstract

The objective of this study was to describe plasma and lipoprotein perturbations in gestational diabetes mellitus (GDM) compared to controls, and determine if alterations in lipids are related to gestational hormones and/or glucose control. Maternal HbA1c, free fatty acids (FFA), beta-estradiol, progesterone, prolactin, and plasma, very-low-density lipoprotein (VLDL), low-density lipoprotein (LDL), high-density lipoprotein (HDL), HDL2 and HDL3 triglyceride (TG), cholesterol, and dietary intake were determined for women with diet-treated GDM and controls in a longitudinal design. Subjects (N = 25/group) were matched for age, race, and body-mass index (BMI). Women with GDM had significantly higher HbA1c than controls, although both groups were within the normal range (4%-6%). However, body weight gain was less for women with GDM. There was a trend for higher plasma FFAs at 37-38 weeks in GDM versus controls. Plasma and lipoprotein TG among the groups increased over the third trimester, and mean concentrations were greater for women with GDM. In GDM versus controls, VLDL and HDL3 TGs were higher at all times, HDL and HDL2 TGs at 33-34 and 37-38 weeks, and LDL TGs at 37-38 weeks. In VLDL, core lipids (TG + cholesterol) increased over gestation and were greater in GDM. In HDL, the TG/cholesterol ratio was greater in GDM. In GDM versus controls, plasma progesterone and prolactin were higher at all times; beta-estradiol was elevated at 37-38 weeks. HbA1c, progesterone, and prolactin correlated with all lipoprotein TG fractions. Exaggerated hypertriglyceridemia, particularly in the VLDL and HDL fractions, is a feature of GDM. The increase in VLDL TG is likely due to an increase in VLDL synthesis, whereas particle enrichment in TG is a plausible explanation for changes in HDL TG. Slight perturbations in glucose control and gestational hormones in diet-treated GDM may contribute to the observed increase in plasma and lipoprotein TG.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9442808     DOI: 10.1016/s1056-8727(97)00007-x

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  13 in total

1.  Maternal lipid profile differs by gestational diabetes physiologic subtype.

Authors:  Jill Layton; Camille Powe; Catherine Allard; Marie-Claude Battista; Myriam Doyon; Luigi Bouchard; Patrice Perron; Jennifer Wessel; Marie-France Hivert
Journal:  Metabolism       Date:  2018-11-20       Impact factor: 8.694

2.  Oleic acid stimulates system A amino acid transport in primary human trophoblast cells mediated by toll-like receptor 4.

Authors:  Susanne Lager; Francesca Gaccioli; Vanessa I Ramirez; Helen N Jones; Thomas Jansson; Theresa L Powell
Journal:  J Lipid Res       Date:  2012-12-30       Impact factor: 5.922

3.  Estradiol (E2) Improves Glucose-Stimulated Insulin Secretion and Stabilizes GDM Progression in a Prediabetic Mouse Model.

Authors:  Moritz Liebmann; Melissa Asuaje Pfeifer; Katharina Grupe; Stephan Scherneck
Journal:  Int J Mol Sci       Date:  2022-06-15       Impact factor: 6.208

4.  Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes.

Authors:  K Krzyzanowska; L Zemany; W Krugluger; G H Schernthaner; F Mittermayer; C Schnack; R Rahman; J Brix; B B Kahn; G Schernthaner
Journal:  Diabetologia       Date:  2008-04-25       Impact factor: 10.122

5.  Hyperglycemia and gestational diabetes suppress placental glycolysis and mitochondrial function and alter lipid processing.

Authors:  Amy M Valent; Haeri Choi; Kevin S Kolahi; Kent L Thornburg
Journal:  FASEB J       Date:  2021-03       Impact factor: 5.191

6.  Expression of ABC Efflux transporters in placenta from women with insulin-managed diabetes.

Authors:  Gregory J Anger; Alex M Cressman; Micheline Piquette-Miller
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

7.  Association of assisted reproductive technology with adverse pregnancy outcomes.

Authors:  Zhang Jie; Ding Yiling; Yu Ling
Journal:  Iran J Reprod Med       Date:  2015-03

8.  The impact of maternal obesity and gestational weight gain on early and mid-pregnancy lipid profiles.

Authors:  Christina M Scifres; Janet M Catov; Hyagriv N Simhan
Journal:  Obesity (Silver Spring)       Date:  2013-12-02       Impact factor: 5.002

9.  Maternal and neonatal circulating markers of metabolic and cardiovascular risk in the metformin in gestational diabetes (MiG) trial: responses to maternal metformin versus insulin treatment.

Authors:  Helen L Barrett; Kathryn L Gatford; Candice M Houda; Miles J De Blasio; H David McIntyre; Leonie K Callaway; Marloes Dekker Nitert; Suzette Coat; Julie A Owens; William M Hague; Janet A Rowan
Journal:  Diabetes Care       Date:  2012-10-09       Impact factor: 19.112

10.  Vitamin D deficiency and dyslipidemia in early pregnancy.

Authors:  Abdulrahman Al-Ajlan; Soundararajan Krishnaswamy; Majed S Alokail; Naji J Aljohani; Amal Al-Serehi; Eman Sheshah; Naemah M Alshingetti; Mona Fouda; Iqbal Z Turkistani; Nasser M Al-Daghri
Journal:  BMC Pregnancy Childbirth       Date:  2015-11-26       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.